His research career in ophthalmology began at Moorfields Eye Hospital in the U.K. and his career as a clinician-researcher has taken him to the Middle East, South Asia, West Africa and North America. He has held faculty positions at Nova Southeastern University and Bascom Palmer Eye Institute in the U.S.A. Dr Spratt is a section editor and peer reviewer for several ophthalmology journals and has published his work in The Lancet and other high quality peer-reviewed medical journals. Dr Spratt’s demonstration of the efficacy of bevacizumab in treating neovascular glaucoma and the Aurolab silicone tube in the surgical treatment of glaucoma in Africa reveals his passion for discovering and disseminating ground-breaking, affordable solutions to some of the most difficult problems faced by ophthalmologists worldwide.